Trial Profile
A phase I clinical trial investigating the pharmacokinetics of AP-2200 and a commercial non-steroidal anti-inflammatory drug in healthy volunteers
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 11 Mar 2016
Price :
$35
*
At a glance
- Drugs AP 2200 (Primary) ; Nonsteroidal anti-inflammatories
- Indications Pain
- Focus Pharmacokinetics
- 11 Mar 2016 New trial record